Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Simpson

Showing results (71-80 of 190) with videos related to

Pageof 19
Sort By:
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1970
A rating scale for extrapyramidal side effectsG M Simpson, J W Angus
Diseases of the Nervous System|July 1, 1976
Psychotic exacerbations produced by neurolepticsG M Simpson, E Varga, J Haher
Journal of Theoretical Biology|May 21, 1977
A paradox in the prognosis of schizophrenia. explanation by a mathematical modelM Branchey, M Meisner, G M Simpson
Journal of the American Academy of Child and Adolescent Psychiatry|May 7, 1999
Antipsychotics in children and adolescentsM Campbell, J L Rapoport, G M Simpson
Psychopharmacology|January 1, 1981
Prediction of steady state plasma and saliva levels of desmethylimipramine using a single dose, single time point procedureT B Cooper, N Bark, G M Simpson
Biological Psychiatry|March 1, 1992
Positive and negative symptoms in schizophrenia: where are the data?J de Leon, G M Simpson, V Peralta
Psychopharmacology Communications|January 1, 1975
A sensitive GLC method for the determination of imipramine and desmethylimipramine using a nitrogen detectorT B Cooper, D Allen, G M Simpson
Biological Psychiatry|February 1, 1975
Neuroleptic-induced Klüver-Bucy syndromeE Varga, E J Haher, G M Simpson
Psychiatric Services (Washington, D.C.)|July 28, 2001
Psychopharmacology: rational and irrational polypharmacyS J Kingsbury, D Yi, G M Simpson
Current Therapeutic Research, Clinical and Experimental|January 1, 1976
An early clinical and toxicity trial of EX 11-582A in chronic schizophreniaG M Simpson, B Zoubok, J H Lee
Pageof 19

Showing results (71-80 of 190) with videos related to

Sort By:
Pageof 19
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1970
A rating scale for extrapyramidal side effectsG M Simpson, J W Angus
Diseases of the Nervous System|July 1, 1976
Psychotic exacerbations produced by neurolepticsG M Simpson, E Varga, J Haher
Journal of Theoretical Biology|May 21, 1977
A paradox in the prognosis of schizophrenia. explanation by a mathematical modelM Branchey, M Meisner, G M Simpson
Journal of the American Academy of Child and Adolescent Psychiatry|May 7, 1999
Antipsychotics in children and adolescentsM Campbell, J L Rapoport, G M Simpson
Psychopharmacology|January 1, 1981
Prediction of steady state plasma and saliva levels of desmethylimipramine using a single dose, single time point procedureT B Cooper, N Bark, G M Simpson
Biological Psychiatry|March 1, 1992
Positive and negative symptoms in schizophrenia: where are the data?J de Leon, G M Simpson, V Peralta
Psychopharmacology Communications|January 1, 1975
A sensitive GLC method for the determination of imipramine and desmethylimipramine using a nitrogen detectorT B Cooper, D Allen, G M Simpson
Biological Psychiatry|February 1, 1975
Neuroleptic-induced Klüver-Bucy syndromeE Varga, E J Haher, G M Simpson
Psychiatric Services (Washington, D.C.)|July 28, 2001
Psychopharmacology: rational and irrational polypharmacyS J Kingsbury, D Yi, G M Simpson
Current Therapeutic Research, Clinical and Experimental|January 1, 1976
An early clinical and toxicity trial of EX 11-582A in chronic schizophreniaG M Simpson, B Zoubok, J H Lee
Pageof 19